Latest KFF Health News Stories
Colorado Legal Settlement Would Up Care and Housing Standards for Trans Women Inmates
A soon-to-be-finalized legal settlement would offer transgender women in Colorado prisons new housing options, including a pipeline to the Denver Women’s Correctional Facility. The change comes amid a growing number of lawsuits across the country aimed at improving health care access and safety for incarcerated trans people.
Possibility of Wildlife-to-Human Crossover Heightens Concern About Chronic Wasting Disease
A response is ramping up to a potential spillover of the neurological disease to humans from deer, elk, and other animals.
Is the Nation’s Primary Care Shortage as Bad as Federal Data Suggest?
Federal policymakers have been trying for a long time to lure more primary care providers to understaffed areas. The Biden administration boosted funding in 2022 to address shortages and Sen. Bernie Sanders (I-Vt.) pushed sweeping primary care legislation in 2023. But when KFF Health News set out last year to map where the primary care workforce shortages really are — and where […]
Médicos deben racionar la penicilina por el dramático aumento de casos de sífilis
A nivel nacional, las tasas de sífilis están en su punto más alto en 70 años. Entre 2018 y 2022, las tasas de esta enfermedad de transmisión sexual subieron alrededor del 80%.
Surge in Syphilis Cases Leads Some Providers to Ration Penicillin
Injectable penicillin is the go-to treatment for syphilis and the only treatment considered safe for pregnant people with the disease. But as rates of syphilis increase across the U.S., a shortage of the injectable has prompted some public health agencies to ration it.
More ‘Navigators’ Are Helping Women Travel to Have Abortions
After the U.S. Supreme Court ended the federal right to an abortion and many states banned the procedure, reproductive health care organizations hired dozens of people to help patients arrange travel and pay for care.
Ketamine Therapy for Mental Health a ‘Wild West’ for Doctors and Patients
Ketamine, approved by the FDA as an anesthetic in 1970, is emerging as a major alternative mental health treatment, and there are now more than 500 ketamine clinics around the country. But with little regulation and widely varying treatment protocols, it’s a medical “wild West.”
The FTC Is Attacking Drugmakers’ ‘Patent Thickets’
It’s a big job clearing out so-called “patent thickets” drugmakers create to keep their products’ prices high. But the Federal Trade Commission is giving it a shot.
Montana Vows Changes to Avoid Delayed Contracts. Some Health Providers Still Await Back Pay.
The head of Montana’s health department said the agency is catching up on a months-long backlog of contracts with organizations that connect people to medical care that left organizations without pay, halted some services, and triggered job cuts.
¿Dónde están los proveedores de atención primaria del país? La respuesta no es fácil
Expertos en el tema sienten una frustración persistente: es difícil saber si alguna política está funcionando porque los datos que recopila el gobierno federal sobre las áreas de escasez de atención primaria no han sido fidedignos durante mucho tiempo.
A Legal Battle Over Herring Fishing Has Big Implications for Health Care
What do herring fishing and health policy have in common? Quite a bit, it turns out, owing to a case now before the Supreme Court. If the justices rule as expected, based on this month’s oral arguments, they could dramatically change the way federal health agencies operate. “The upheaval caused … would be immense,” argues […]
Where Are the Nation’s Primary Care Providers? It’s Not an Easy Answer
Politicians keep talking about fixing primary care shortages. But flawed national data leaves big holes in how to evaluate which policies are effective.
Records Show Publix Opioid Sales Grew Even as Addiction Crisis Prompted Other Chains’ Pullback
As national prescription drug distributors and pharmacies restricted the flow of oxycodone and other painkillers in response to the growing opioid crisis, Florida’s most popular grocery store ramped up its sales and distribution of the highly addictive drugs, according to a Tampa Bay Times analysis of federal data.
Readers Weigh Downsides of Medicare Advantage and Stick Up for Mary Lou Retton
KFF Health News gives readers a chance to comment on a recent batch of stories.
How Fringe Anti-Science Views Infiltrated Mainstream Politics — And What It Means in 2024
Opposition to vaccines and other public health measures backed by science has become politically charged. That makes dangerous misinformation much harder to fight.
A Record Number of Californians Are Visiting Emergency Rooms for Dog Bites
There were nearly 50,000 emergency room visits for dog bites in California in 2022. The rate of such visits per capita is up about 70% since 2005.
Ouch. That ‘Free’ Annual Checkup Might Cost You. Here’s Why.
The designers of the Affordable Care Act might have assumed that they spelled out with sufficient clarity that millions of Americans would no longer have to pay for certain types of preventive care. But they didn’t reckon with America’s ever-creative medical billing juggernaut.
Prescribing Love: Send Us Your Health Policy Valentines
We want your sweetest “Health Policy Valentines.” Submissions will be judged by an esteemed panel of experts. We’ll share favorites on our social media channels, and tenderhearted members of our staff will pick the winners, announced on Feb. 14.
Senate Probes the Cost of Assisted Living and Its Burden on American Families
In the wake of a KFF Health News-New York Times series, members of the Special Committee on Aging are asking residents and their families to submit their bills and are calling for a Government Accountability Office study.
The FTC Escalates Biden’s Fight Against Drug Prices
It’s daggers out at the Federal Trade Commission in its fight against anticompetitive practices in health care. This past year, it has issued more stringent guidelines to block and discourage hospital mergers, and it investigated practices by middlemen in the drug supply chain. Now drug manufacturers themselves are in the agency’s crosshairs. In November, the FTC challenged the validity of more […]
